recombinant interleukin-21

DRUG4 trials

Sponsors

Novo Nordisk A/S

Conditions

CancerMalignant MelanomaOvarian CancerRenal Cell Carcinoma

Phase 2

Efficacy Study of IL-21 to Treat Metastatic Melanoma

CompletedNCT00336986

Novo Nordisk A/SCancer, Malignant Melanoma

Start: 2004-09-30End: 2007-10-31Updated: 2023-08-14

Efficacy Study of Recombinant Interleukin-21 in the Treatment of Ovarian Cancer

CompletedNCT00523380

Novo Nordisk A/SCancer, Ovarian Cancer

Start: 2007-10-04End: 2009-01-07Updated: 2017-03-01

Effect of rIL-21 on Metastases in Lymph Nodes in Melanoma Skin Cancer

TerminatedNCT00601861

Novo Nordisk A/SCancer, Malignant Melanoma

Start: 2008-02-13End: 2008-06-25Updated: 2017-03-01

Combination of Recombinant Human IL-21 (rIL-21) and Sunitinib in Stage IV Renal Cell Carcinoma Patients

CompletedNCT00617253

Novo Nordisk A/SCancer, Renal Cell Carcinoma

Start: 2007-07-12End: 2008-06-30Updated: 2017-03-01